A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News